Abstract
The National Institute for Health and Clinical Excellence (hereafter NICE) was created in 1998 to give guidance on which treatments should be provided by the British National Health Service, and to whom. So it has a crucial role as an agent of distributive justice. In this paper I argue that it is failing to adequately explain and justify its decisions in the public arena, particularly in terms of distributive justice; and that this weakens its legitimacy, to the detriment of the National Health Service as a whole. I argue that this failure arises from the fact that NICE works within the frameworks of positivist science and liberal ethics, largely to the exclusion of other perspectives. This narrowness of view prevents NICE from properly connecting with the range of moral concerns represented in the population. I argue for NICE’s deliberations to become more inclusive, both in terms of epistemology, and also in terms of ethical perspectives. And I suggest a range of perspectives that could usefully be included. Finally I offer a framework of structures, philosophies and discussion process that will enable competing perspectives to be debated fairly and productively in this process.
Similar content being viewed by others
References
Bentham, J. 1962. Introduction to the principles of morals and legislation. In Utilitarianism, ed. M. Warnock. London: Collins.
Berniker, E., and D. McNabb. 2006. Dialectical inquiry: A structured qualitative research method. Qualitative Report 11(4): 643–664.
Braun, K. 2005. Not just for experts: The public debate about reprogenetics in Germany. Hastings Center Report 35(3): 42–49.
Brown, M. 2009. Three ways to politicize bioethics. American Journal of Bioethics 9(2): 43–54.
Bryman, A. 1992. Quality and quantity in social research. London: Routledge.
Callahan, D. 2003. Individual good and common good. Perspectives in Biology and Medicine 46(4): 496–507.
Churchman, C.W. 1971. The design of inquiring systems. New York: Basic Books.
Culyer, A.J. 2005. Involving stakeholders in health care decisions the experience of the National Institute for Health and Clinical Excellence (NICE) in England and Wales. Healthcare Quarterly 8(3): 56–60.
Culyer, A.J. 2006. NICE’s use of cost effectiveness as an exemplar of a deliberative process. Health Economics, Policy and Law 1(3): 299–318.
Daniels, N., and J. Sabin. 1997. Limits to health care: Fair procedures, democratic deliberation and the legitimacy problem for insurers. Philosophy & Public Affairs 26(4): 302–396.
De Marco, J., and P. Ford. 2006. Balancing in ethical deliberation: Superior to specification and casuistry. Journal of Medicine and Philosophy 31(5): 483–497.
Dolan, P. 2001. Utilitarianism and the measurement and aggregation of quality-adjusted life years. Health Care Analysis 9(1): 69–76.
Gilardi, F. 2008. Delegation in the regulatory state: Independent regulatory agencies in Western Europe. Cheltenham: Edward Elgar.
Guba, E., and Y. Lincoln. 2004. Competing paradigms. In Approaches to qualitative research, ed. S. Nagy Hesse-Biber, and P. Leavy, 17–38. New York: Oxford University press.
Harris, J. 2005. Its not NICE to discriminate. Journal of Medical Ethics 31(7): 373–375.
Hasman, A. 2008. The accountability problem of the National Institute for Health and Clinical Excellence. Medicine and Law 27(1): 83–93.
Ipperciel, D. 2003. Dialogue and decision in a moral context. Nursing Philosophy 4(3): 211–221.
Kuczewski, M. 2001. The epistemology of communitarian bioethics: traditions in the public debates. Theoretical Medicine and Bioethics 22(2): 135–150.
Lind, E., C. Kulick, M. Ambrose, and M. de Vera Park. 1993. Individual and corporate dispute resolution: Using procedural fairness as a decision heuristic. Administrative Science Quarterly 38(2): 224–251.
Littlejohns, P., N. Doyle, F. Macbeth, D. Barnett, and C. Londson. 2009. 10 years of NICE: Still growing and still controversial. Lancet Oncology 10(4): 417–424.
MacIntyre, A. 1988. Whose Justice? Which Rationality? Notre Dame Indiana: University of Notre Dame Press.
Malhotra, Y. 2000. Knowledge Management and Virtual Organisations. Hershey: IGP.
Milewa, T. 2005. Representation and legitimacy in health policy formulation at a national level: Perspectives from a study of health technology eligibility procedures in the United Kingdom. Health Policy 85(3): 356–362.
Moon, J.D. 1993. Constructing community: Moral pluralism and tragic conflicts. Princeton: Princeton University Press.
Mulhall, S., and A. Swift. 1996. Liberals and communitarians. Oxford: Blackwell.
NICE. 2008. Social value judgements: Principles for the development of NICE guidance, 2nd ed. London: National Institute for Health and Clinical Excellence.
NICE. 2009. The guidelines manual. London: National Institute for Health and Clinical Excellence.
Palys, T. 2003. Research decisions: Quantitative and qualitative perspectives. Scarborough: Thomson.
Pearson, S., and M. Rawlins. 2005. Quality, innovation and value for money. JAMA 294(20): 2618–2622.
Rawlins, M.D. 2005. Pharmacopolitics and deliberative democracy. Clinical Medicine 5(5): 471–475.
Rawls, J. 1971. A theory of justice. Cambridge: Harvard University Press.
Rawls, J. 1993. Political liberalism. New York: Columbia University Press.
Rockmore, T. 2005. On constructivist epistemology. Lanham: Rowman and Littlefield.
Scharpf, F.W. 1999. Governing in Europe: Effective and democratic? Oxford: Oxford University Press.
Taylor, C. 1992. Multiculturalism and the politics of recognition. Princeton: Princeton University Press.
Taylor-Gooby, P. 2008. Trust and welfare state reform: the example of the NHS. Social Policy and Administration 42(1): 288–306.
Thatcher, M., and A. Stone Sweet. 2002. Theory and practice of delegation to non-majoritarian institutions. West European Politics 25(1): 1–22.
Thomson, E., J. Farmer, J. Tucker, and H. Bryers. 2008. Informing debate or fuelling dispute? Media communication of reconfiguration in Scotland’s rural maternity care. Social Policy and Administration 42(7): 789–812.
Trotter, G. 2006. Bioethics and liberal democracy: five warnings from Hobbes. Journal of Medicine and Philosophy 31(3): 235–250.
Turner, L. 2004. Bioethics in pluralistic societies. Medicine, Health Care and Philosophy 7(2): 201–208.
Wilson, P., A. Booth, A. Eastwood, and I.D. Watt. 2008. Deconstructing media coverage of Trastuzumab (Herceptin): An analysis of national newspaper coverage. Journal of the Royal Society of Medicine 101(3): 125–132.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wilmot, S. Evidence, ethics and inclusion: a broader base for NICE. Med Health Care and Philos 14, 111–121 (2011). https://doi.org/10.1007/s11019-010-9256-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11019-010-9256-1